Lord's Mark Industries Limited is expanding its global footprint through a significant strategic partnership with ARKALL Holdings Limited, focusing on establishing and operating pathology laboratories and growing its medical devices, equipment, and healthcare portfolio across all 28 Caribbean countries. This collaboration marks a substantial entry into the Caribbean market for the Indian healthcare company, beginning with Trinidad & Tobago and progressing to the wider region over three years. ARKALL Holdings will be responsible for investments in operational scaling and commercialization, while Lord's Mark will provide a comprehensive suite of IVD products, medical equipment like dialysis machines, and essential technical and training support. The venture aims to build a robust healthcare infrastructure, leveraging advanced medical technology and diagnostics, and is anticipated to generate significant export revenue while addressing a considerable market opportunity in pathology and diagnostics.

Lord's Mark Industries Limited is expanding its global footprint through a significant strategic partnership with ARKALL Holdings Limited, focusing on establishing and operating pathology laboratories and growing its medical devices, equipment, and healthcare portfolio across all 28 Caribbean countries. This collaboration marks a substantial entry into the Caribbean market for the Indian healthcare company, beginning with Trinidad & Tobago and progressing to the wider region over three years. ARKALL Holdings will be responsible for investments in operational scaling and commercialization, while Lord's Mark will provide a comprehensive suite of IVD products, medical equipment like dialysis machines, and essential technical and training support. The venture aims to build a robust healthcare infrastructure, leveraging advanced medical technology and diagnostics, and is anticipated to generate significant export revenue while addressing a considerable market opportunity in pathology and diagnostics.

Lord's Mark Industries Limited is expanding its global footprint through a significant strategic partnership with ARKALL Holdings Limited, focusing on establishing and operating pathology laboratories and growing its medical devices, equipment, and healthcare portfolio across all 28 Caribbean countries. This collaboration marks a substantial entry into the Caribbean market for the Indian healthcare company, beginning with Trinidad & Tobago and progressing to the wider region over three years. ARKALL Holdings will be responsible for investments in operational scaling and commercialization, while Lord's Mark will provide a comprehensive suite of IVD products, medical equipment like dialysis machines, and essential technical and training support. The venture aims to build a robust healthcare infrastructure, leveraging advanced medical technology and diagnostics, and is anticipated to generate significant export revenue while addressing a considerable market opportunity in pathology and diagnostics.

Lord's Mark Industries Limited has signed a strategic partnership agreement with ARKALL Holdings Limited, a Caribbean based company, to set up and run pathology laboratories and grow its medical devices, medical equipment and healthcare portfolio within all 28 Caribbean countries. With a range of products that are pre-approved, the company is offering a comprehensive portfolio that includes diagnostics, MedTech and healthcare solutions, which is Lord's Mark Industries Limited's first foray, and one of the biggest by an Indian healthcare company in the Caribbean market.

The partnership will begin in Trinidad & Tobago and will gradually expand to the wider Caribbean in the next three years. Investments to establish and grow the scale of operations of the pathologists' laboratory, as well as investments to commercialise Lord's Mark's healthcare portfolio throughout the Caribbean will be made by ARKALL Holdings Limited.

Under the proposed collaboration, Lord’s Mark Industries Limited will supply its comprehensive range of IVD products, including rapid test kits, biochemistry reagents, pathology laboratory products, medical equipment, dialysis machines and related healthcare solutions. The Company will also provide technical guidance, product knowledge, training and operational support. ARKALL Holdings Limited will lead commercialisation and market development activities across the agreed Caribbean markets.

The partnership is expected to create a scalable healthcare platform combining pathology and diagnostics infrastructure with access to medical technology and equipment. The companies will initially undertake market assessment and business planning in Trinidad & Tobago before progressively expanding operations across the remaining Caribbean markets.

Based on the company’s current projections, Lord’s Mark Industries Limited expects to generate approximately US $100 million in export revenue between FY27 and FY31 through the phased Caribbean rollout. The company’s internal planning assessment estimates an indicative pathology and diagnostics opportunity of approximately US$1.24 billion across the 28 Caribbean markets, with potential business opportunity increasing with market penetration as the laboratory network matures.

Commenting on the partnership, a Senior Management Representative from ARKALL Holdings Limited said, “The Caribbean presents an important opportunity to strengthen healthcare infrastructure through greater access to quality diagnostics, medical technology and specialised healthcare solutions. Our partnership with Lord’s Mark Industries Limited brings together local market capabilities with an expanding portfolio of healthcare technologies. Beginning with Trinidad & Tobago, our objective is to build a scalable network that can progressively serve healthcare needs across all 28 Caribbean markets.”

Dr. Sachidanand Upadhyay, Managing Director & CEO, Lord’s Mark Industries Limited, said, “Our collaboration with ARKALL Holdings Limited marks an important step in taking Lord’s Mark’s healthcare and MedTech capabilities to a wider international market. The Caribbean expansion will allow us to combine our medical technology, pathology and dialysis capabilities with ARKALL’s regional commercial presence. We see this partnership as a long-term platform for expanding our export footprint while contributing to the development of accessible and technology-enabled healthcare infrastructure across the region.”

The collaboration is structured around a phased expansion model, with market penetration expected to build progressively as new laboratories become operational and existing markets mature. Lord’s Mark will also support product registrations and regulatory processes by providing the required technical and product-related documentation for its portfolio across the region.

The companies will undertake the initial market assessment and implementation planning in Trinidad & Tobago, following which the expansion roadmap will be progressively implemented across the Caribbean.

For More Details Visit :- https://lordsmark.com/